Research Tracker›Biomarker Atlas›Long COVID›Interleukin-8 (IL-8)

Interleukin-8 (IL-8) in Long COVID

Interleukin-8 (IL-8), also described as CXCL8, belongs to the inflammatory group of Long COVID (PASC, Post-Acute Sequelae of COVID-19) markers and is reported to be raised relative to healthy controls. The cited literature links this alteration to neutrophil chemotaxis. The finding is drawn from Thomas et al. 2024; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedInflammatoryLOINC 26998-9

Summary

Direction in Long COVID↑ Elevated — higher than in the comparison group
CategoryInflammatory
Also described asCXCL8
Compared againstHC (healthy controls)
Associated symptomsNeutrophil chemotaxis
Test typeBlood test (serum / plasma / whole blood)
LOINC code26998-9
SourceThomas et al. 2024 — doi:10.1007/s40291-024-00731-z
Condition atlasLong COVID Biomarker Atlas

Other conditions where Interleukin-8 (IL-8 / CXCL8) is reported

See the cross-condition hub: Interleukin-8 (IL-8 / CXCL8) across conditions.

Trials, interventions and tests

Commercial test availability

Interleukin-8 (IL-8) — specialty laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Inflammatory markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is Interleukin-8 (IL-8) high or low in Long COVID?

Elevated. Studies summarised in the OSMF atlas report higher Interleukin-8 (IL-8) in Long COVID than in healthy controls. Source: Thomas et al. 2024.

What symptoms is Interleukin-8 (IL-8) associated with in Long COVID?

The cited literature associates this marker with Neutrophil chemotaxis. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Interleukin-8 (IL-8)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 26998-9. Commercial laboratories such as Quest Diagnostics, LabCorp list an orderable assay.

Is one abnormal Interleukin-8 (IL-8) result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. Interleukin-8 (IL-8) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Interleukin-8 (IL-8) specific to Long COVID?

No. The same marker is also reported in Gulf War Illness, ME/CFS, PACVS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Interleukin-8 (IL-8) in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/interleukin-8-il-8.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.